Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study observed that among 206 children in India, skin infections and infestations were the most common skin conditions, highlighting a significant burden in developing countries and underscoring the importance of awareness and treatment in pediatric dermatological care.

This study observed that tofacitinib therapy over about 16 weeks had a positive effect in children with alopecia areata, reducing the SALT index significantly in some patients.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

This study analyzed dermatology cases in children during the COVID-19 lockdown in India, finding that most conditions, including pruritic and non-emergency skin diseases, could have been managed through teleconsultation instead of in-person visits.

This study found that skin changes, such as xerosis and pruritus, are common in children with chronic kidney disease and are primarily related to the disease itself rather than haemodialysis.

This review discusses the skin manifestations associated with metabolic syndrome and related conditions in young populations, noting associations with obesity, insulin resistance, and neonatal obesity, but reports no new clinical results.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Zinc deficiency is linked to respiratory infections in children.

This study observed that in children who unintentionally consumed high-dose oral minoxidil, 65% developed hypertrichosis, predominantly on the face, and 15% experienced mild systemic side effects.

This systematic review reports promising efficacy and safety of Tofacitinib for treating Alopecia Areata in children, though further randomized studies are needed due to the low quality of existing evidence.

Among pediatric alopecia areata patients treated with DPCP, this study reported complete hair regrowth in 8.8% and any regrowth in 61.8% after one year, with better outcomes for those with milder initial symptoms and longer treatment durations.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

In this study, oral tofacitinib significantly reduced alopecia severity in pediatric patients with moderate-to-severe alopecia areata over 24 weeks, with 42.2% achieving complete or near-complete hair regrowth, although further research is needed on long-term safety and relapse rates.

This study retrospectively evaluated the effectiveness of off-label baricitinib in children with severe alopecia areata and found that 50% achieved treatment goals, though psychological effects were noted and laboratory abnormalities occurred in 42.86% of patients.

In this study, researchers described cases of traction alopecia in young Sikh boys due to hair tying practices, emphasizing the importance of early intervention and education to prevent progression and support hair regrowth, using strategies like changing hair tying methods and topical treatments when appropriate.

In this case study, a 13-year-old boy with dissecting cellulitis of the scalp showed improvement in inflammatory lesions and hair regrowth after treatment with isotretinoin, sublingual minoxidil, and oral prednisolone, marking the youngest reported male case of this condition.

This literature review indicates that tofacitinib, both orally and topically, holds promise as a safe and effective treatment for various dermatological conditions in pediatric patients, though its use requires careful consideration of its benefits and risks.

This case series reports favorable outcomes for children with Parry Romberg Syndrome who underwent facial fat-grafting, showing it as a safe and well-tolerated procedure with no complications or relapses observed.

This review discusses the use of mesenchymal stem cells in treating diseases, particularly focusing on their application in pediatric Graft-versus-Host Disease, with most studies reporting safety and effectiveness in animals.

Among pediatric patients in this study, eczema was identified as the most prevalent noninfectious skin condition across all age groups, but more research is needed for comprehensive understanding.

This case report describes an eight-year-old male with alopecia areata who achieved complete remission within five months following a diet and supplementation regimen rich in vitamins and zinc.

This study reports on a patient's case with support data available on request but provides no new research findings.

This study observed that in a real-world pediatric setting, Janus kinase inhibitors led to improvements in scalp, eyebrow, and eyelash involvement in children with alopecia areata, with a generally favorable tolerability profile, though baseline imbalances and non-randomized treatment allocation limit causal conclusions and drug comparisons.

In this study, a rare case of a trichilemmal cyst in a 6-year-old's upper eyelid was observed; it was identified through histopathological examination after excision, highlighting the importance of considering trichilemmal cysts in atypical pediatric eyelid swellings.

This case series highlighted three pediatric patients with congenital nail anomalies, revealing underlying developmental or genetic issues such as symbrachydactyly and potential Adams–Oliver syndrome, underscoring the critical role of dermatologists in early detection and diagnosis of these conditions.

Results are not reported in this abstract. The study's title, purpose, or specific focus is not provided, making it unclear what research question was addressed.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

This case report describes successful treatment of alopecia areata and atopic dermatitis in a pediatric patient using the Janus kinase 1 inhibitor upadacitinib, with significant hair growth improvements noted after six weeks.

This case report describes a rare instance of trichotillomania, tricophagia, and a gastric trichobezoar in an 11-year-old boy, emphasizing the importance of a multidisciplinary approach involving surgery and psychiatric evaluation to address this uncommon psychiatric disorder.